Rohto Pharmaceutical Co Ltd (RPHCF)
OTHER OTC:RPHCF
Holding RPHCF?
Track your performance easily

Rohto Pharmaceutical Co (RPHCF) Income Statement

3 Followers

Rohto Pharmaceutical Co Income Statement

Last quarter (Q3 2022), Rohto Pharmaceutical Co's total revenue was ¥65.95B, an increase of 24.43% from the same quarter last year. In Q3, Rohto Pharmaceutical Co's net income was ¥8.45B. See Rohto Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Mar 22Mar 21Mar 20Mar 19Mar 18
Total Revenue
¥ 173.83B¥ 199.65B¥ 181.05B¥ 188.38B¥ 183.67B¥ 171.79B
Cost of Revenue
¥ 72.78B¥ 83.16B¥ 74.33B¥ 74.14B¥ 74.05B¥ 70.75B
Gross Profit
¥ 101.05B¥ 116.49B¥ 106.73B¥ 114.24B¥ 109.62B¥ 101.05B
Operating Expense
¥ 74.61B¥ 87.14B¥ 83.73B¥ 91.68B¥ 88.81B¥ 81.96B
Operating Income
¥ 26.44B¥ 29.35B¥ 22.99B¥ 22.56B¥ 20.82B¥ 19.09B
Net Non Operating Interest Income Expense
¥ 300.00M¥ 120.00M¥ 196.00M¥ 359.00M¥ 229.00M¥ 211.00M
Other Income Expense
------
Pretax Income
¥ 25.78B¥ 27.95B¥ 23.01B¥ 21.73B¥ 16.30B¥ 16.82B
Tax Provision
¥ 6.11B¥ 6.80B¥ 6.24B¥ 6.45B¥ 6.48B¥ 7.48B
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
¥ 19.52B¥ 21.02B¥ 16.74B¥ 15.41B¥ 9.80B¥ 9.29B
Basic EPS
¥ 134.15¥ 92.13¥ 146.78¥ 135.13¥ 86.00¥ 81.55
Diluted EPS
¥ 133.76¥ 91.86¥ 146.36¥ 134.71¥ 85.66¥ 81.20
Basic Average Shares
¥ 456.28M¥ 228.14M¥ 114.07M¥ 114.04M¥ 113.95M¥ 113.92M
Diluted Average Shares
¥ 457.59M¥ 228.79M¥ 114.40M¥ 114.39M¥ 114.39M¥ 114.40M
Dividend Per Share
¥ 21.00¥ 18.00¥ 14.00¥ 26.00¥ 23.00¥ 11.00
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
¥ 147.39B¥ 170.29B¥ 158.06B¥ 165.81B¥ 162.85B¥ 152.71B
Net Income From Continuing And Discontinued Operation
¥ 19.52B¥ 21.02B¥ 16.74B¥ 15.41B¥ 9.80B¥ 9.29B
Normalized Income
¥ 20.30B¥ 22.75B¥ 18.15B¥ 15.74B¥ 11.38B¥ 10.69B
Interest Expense
¥ 258.00M¥ 248.00M¥ 145.00M¥ 125.00M¥ 148.00M¥ 143.00M
EBIT
¥ 26.03B¥ 28.20B¥ 23.15B¥ 21.86B¥ 16.45B¥ 16.96B
EBITDA
¥ 26.03B¥ 35.87B¥ 29.90B¥ 28.79B¥ 22.85B¥ 22.88B
Currency in JPY

Rohto Pharmaceutical Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis